To participate, please dial one of the following numbers and ask to join the Verona Pharma call: A live webcast will be available on the Events and Presentations link on the Investors page of the ...

LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory diseases, has ...

Investors with a lot of money to spend have taken a bearish stance on Verona Pharma (NASDAQ:VRNA). And retail traders should know. We noticed this today when the trades showed up on publicly ...

LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory ...

Term loan facility increased to $450 million with more favorable terms Access to up to an additional $200 million LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc ...

(RTTNews) - Verona Pharma plc (VRNA), Friday announced some strategic changes in its capital structure, increasing the company's financial flexibility and simplifying its balance sheet. The ...